Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 2000, p. 9399-9408, Vol. 20, No. 24
Department of Microbiology and
Immunology, Stanford University School of Medicine, Stanford,
California 94305-5124
Received 21 June 2000/Returned for modification 24 August
2000/Accepted 20 September 2000
Toxoplasma gondii is an obligate intracellular pathogen
within the phylum Apicomplexa. Invasion and egress by this protozoan parasite are rapid events that are dependent upon parasite motility and
appear to be directed by fluctuations in intracellular
[Ca2+]. Treatment of infected host cells with the calcium
ionophore A23187 causes the parasites to undergo rapid egress in a
process termed ionophore-induced egress (IIE). In contrast, when
extracellular parasites are exposed to this ionophore, they quickly
lose infectivity (termed ionophore-induced death [IID]). From among
several Iie
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Ionophore-Resistant Mutants of Toxoplasma
gondii Reveal Host Cell Permeabilization as an Early Event
in Egress

mutants described here, two were identified
that differ in several attributes, most notably in their resistance to
IID. The association between the Iie
and
Iid
phenotypes is supported by the observation that
two-thirds of mutants selected as Iid
are also
Iie
. Characterization of three distinct classes of IIE
and IID mutants revealed that the Iie
phenotype is due to
a defect in a parasite-dependent activity that normally causes infected
host cells to be permeabilized just prior to egress. Iie
parasites underwent rapid egress when infected cells were artificially permeabilized by a mild saponin treatment, confirming that this step is
deficient in the Iie
mutants. A model is proposed that
includes host cell permeabilization as a critical part of the signaling
pathway leading to parasite egress. The fact that Iie
mutants are also defective in early stages of the lytic cycle indicates
some commonality between these normal processes and IIE.
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, Fairchild Building, Room D305, 300 Pasteur Dr., Stanford University School of Medicine, Stanford, CA 94305-5124. Phone: (650) 723-7984. Fax: (650) 723-6853. E-mail:
john.boothroyd{at}stanford.edu.
Present address: Medical Research Council, Laboratory of Molecular
Biology, Cambridge CB2 2QH, United Kingdom.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»